apidel.com
域名年龄: 13年6个月18天HTTP/1.1 302 Found 访问时间:2019年06月29日 03:00:28 目标网址:https://apidel.com/ 文件大小:203 类型:text/html; charset=iso-8859-1 文件时间(秒):0 连接:keep-alive HTTP/1.1 301 永久重定向 访问时间:2019年06月29日 03:00:28 目标网址:http://www.apidel.com/ 文件大小:230 类型:text/html; charset=iso-8859-1 文件时间(秒):0 Strict-Transport-Security: max-age=15768000 HTTP/1.1 302 Found 访问时间:2019年06月29日 03:00:28 目标网址:https://www.apidel.com/ 文件大小:207 类型:text/html; charset=iso-8859-1 文件时间(秒):0 连接:keep-alive HTTP/1.1 200 OK 访问时间:2019年06月29日 03:00:28 动作:X-Forwarded-Proto,Accept-Encoding 缓存控制:max-age=0 过期时间:2019年06月29日 03:00:28 Content-Encoding: gzip 客户端设定:IE=edge X-Content-Type-Options: nosniff 文件大小:12032 类型:text/html; charset=UTF-8 文件时间(秒):0 接受单位:字节 Strict-Transport-Security: max-age=15768000 网站编码:UTF-8
About Us Technologies ApidSOL™ ApidCOR™ Product pipeline Publications Intellectual property Partnering News Contact Innovativedrug deliveryfor exceptional therapeutics Learn More Our patented TechnologiesOur pipelinePartnering Apidel develops pharmaceutical products and provides innovative and more effective drug delivery solutions. Our patented technologiesApidSOL™ApidSOL™ is an aqueous micelle formulation capable of solubilizing poorly soluble drugs. ApidSOL™ is well tolerated and increases tissue penetration following application on the skin, … Learn more ApidCOR™ApidCOR™ is a sustained release drug delivery system. ApidCOR™ a homogenous liquid polymer that can readily be injected. Following a single injection, the tailored duration of activity extends over days, weeks or months. Learn more PartneringApidel welcomes the opportunity to partner with large and small companies in the pharmaceutical and biotechnology fields to bring the benefits of its drug delivery technology together with particular compounds or to address particular therapeutic or market needs. DermatologyGastroenterologyOphthalmologyOncologyOtologyLong-acting sustained-releaseLearn more Latest News March 15, 2019ApidSOL™ Technology featured in a leading pharmaceutical journalTopical tacrolimus skin penetration and ApidSOL™ technology probed for the first time by high spatial resolution X-ray microscopy technique is the subject of a peer-reviewed publication in the European Journal of Pharmaceutics and…Read More February 27, 2019ApidSOL™ Technology is the subject of a peer reviewed publicationNew publication in the European Journal of Pharmaceutics and Biopharmaceutics is featuring ApidSOL™ technology and its delivery efficiency. Therapeutically relevant levels of Imiquimod (poorly soluble drug) in target tissue have been…Read More May 30, 2018Apidel has received a granted patent from the USPTOApidel SA has the pleasure to announce that the patent application entitled "POLYLACTIDE COMPOSITIONS AND USES THEREOF" has been granted in the USA with the following patent number: US 9,925,267 B2. Read More Head OfficeApidel SA The Business Harbour 29 Quai du Mont Blanc 1201 Geneva – Switzerland Phone : +41 22 731 2180 Laboratory siteApidel SA (c/o Eclosion) 14 Chemin des Aulx 1228 Plan-les-Ouates, Geneva – Switzerland Phone : +41 22 884 1900 TechnologiesApidCOR™ ApidSOL™ Product pipeline Publications Intellectual property Contact UsContact Us © 2017 UX UI Design by Coteries Lab Lausanne
© 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询
2024-10-24 01:27, Process in 0.0049 second.